Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 57 articles: HTML format

Single Articles

April 2024
1. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
   Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
   N Engl J Med. 2024;390:1196-1206.
   PubMed     Abstract available
   
   
   December 2023
2. JAUREGUI R, Busis NA
   Idiopathic Intracranial Hypertension.
   N Engl J Med. 2023;389:2467.
   PubMed    
   
   
   November 2023
3. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
   Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
   N Engl J Med. 2023;389:1685-1692.
   PubMed     Abstract available
   
   
   October 2023
4. DESAI AS, Sweetser MT, Bakris GL
   Zilebesiran for Hypertension. Reply.
   N Engl J Med. 2023;389:1439-1440.
   PubMed    
   
   
   
5. VAN TWIST DJL, Kalic H
   Zilebesiran for Hypertension.
   N Engl J Med. 2023;389:1438-1439.
   PubMed    
   
   
   
6. LIFSCHITZ M
   Zilebesiran for Hypertension.
   N Engl J Med. 2023;389:1438.
   PubMed    
   
   
   
7. ABASHEVA D, Fernandez-Fernandez B, Ortiz A
   Zilebesiran for Hypertension.
   N Engl J Med. 2023;389:1438.
   PubMed    
   
   
   July 2023
8. TOUYZ RM
   Silencing Angiotensinogen in Hypertension.
   N Engl J Med. 2023;389:278-281.
   PubMed    
   
   
   
9. DESAI AS, Webb DJ, Taubel J, Casey S, et al
   Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
   N Engl J Med. 2023;389:228-238.
   PubMed     Abstract available
   
   
   May 2023
10. FREEMAN MW, Halvorsen YD, Brown MJ
    Baxdrostat for Treatment-Resistant Hypertension. Reply.
    N Engl J Med. 2023;388:1821-1822.
    PubMed    
    
    
    
11. FISK M
    Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:1821.
    PubMed    
    
    
    
12. D'ALLESANDRO N, Hough A, Parra D
    Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:1820-1821.
    PubMed    
    
    
    
13. KIDA Y
    Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:1820.
    PubMed    
    
    
    
14. SIMMONS D, Immanuel J, Hague WM, Teede H, et al
    Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.
    N Engl J Med. 2023 May 5. doi: 10.1056/NEJMoa2214956.
    PubMed     Abstract available
    
    
    April 2023
15. ISHANI A, Cushman WC, Leatherman SM
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. Reply.
    N Engl J Med. 2023;388:1342.
    PubMed    
    
    
    
16. FRAVEL MA, Ernst ME
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1342.
    PubMed    
    
    
    
17. MESSERLI FH
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1341-1342.
    PubMed    
    
    
    March 2023
18. HOEPER MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al
    Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMoa2213558.
    PubMed     Abstract available
    
    
    
19. TAICHMAN DB, Leopold JA, Elliott G
    Continued Progress in Therapy for Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMe2300324.
    PubMed    
    
    
    February 2023
20. LEOPOLD JA, Ingelfinger JR
    Aldosterone and Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:464-467.
    PubMed    
    
    
    
21. AZIZI M
    Decreasing the Effects of Aldosterone in Resistant Hypertension - A Success Story.
    N Engl J Med. 2023;388:461-463.
    PubMed    
    
    
    December 2022
22. INGELFINGER JR
    Thiazide-like versus Thiazide Diuretics - Finally, an Answer?
    N Engl J Med. 2022;387:2462-2463.
    PubMed    
    
    
    
23. ISHANI A, Cushman WC, Leatherman SM, Lew RA, et al
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2212270.
    PubMed     Abstract available
    
    
    November 2022
24. FREEMAN MW, Halvorsen YD, Marshall W, Pater M, et al
    Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2022 Nov 7. doi: 10.1056/NEJMoa2213169.
    PubMed     Abstract available
    
    
    September 2022
25. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.
    PubMed     Abstract available
    
    
    August 2022
26. TITA AT, Szychowski JM, Andrews WW
    Treatment for Mild Chronic Hypertension during Pregnancy. Reply.
    N Engl J Med. 2022;387:664.
    PubMed    
    
    
    
27. MAGEE LA, von Dadelszen P
    Treatment for Mild Chronic Hypertension during Pregnancy.
    N Engl J Med. 2022;387:664.
    PubMed    
    
    
    
28. GLEESON PJ, O'Seaghdha CM
    Treatment for Mild Chronic Hypertension during Pregnancy.
    N Engl J Med. 2022;387:663-664.
    PubMed    
    
    
    April 2022
29. AGARWAL R, Sinha AD, Tu W
    Chlorthalidone for Hypertension in Advanced CKD. Reply.
    N Engl J Med. 2022;386:1384.
    PubMed    
    
    
    
30. AFSAR B, Kanbay M, Elsurer Afsar R
    Chlorthalidone for Hypertension in Advanced CKD.
    N Engl J Med. 2022;386:1383-1384.
    PubMed    
    
    
    
31. ELIAS R, Zatz R
    Chlorthalidone for Hypertension in Advanced CKD.
    N Engl J Med. 2022;386:1382-1383.
    PubMed    
    
    
    
32. LINDNER G, Ravioli S
    Chlorthalidone for Hypertension in Advanced CKD.
    N Engl J Med. 2022;386:1382.
    PubMed    
    
    
    
33. GREENE MF, Williams WW
    Treating Hypertension in Pregnancy.
    N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMe2203388.
    PubMed    
    
    
    
34. TITA AT, Szychowski JM, Boggess K, Dugoff L, et al
    Treatment for Mild Chronic Hypertension during Pregnancy.
    N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMoa2201295.
    PubMed     Abstract available
    
    
    February 2022
35. ELLISON DH, Welling P
    Insights into Salt Handling and Blood Pressure. Reply.
    N Engl J Med. 2022;386:e18.
    PubMed    
    
    
    
36. JOHNSON RJ, Lanaspa MA, Rodriguez-Iturbe B
    Insights into Salt Handling and Blood Pressure.
    N Engl J Med. 2022;386:e18.
    PubMed    
    
    
    
37. HU B, Li W, Zhou H
    Insights into Salt Handling and Blood Pressure.
    N Engl J Med. 2022;386:e18.
    PubMed    
    
    
    
38. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    
    
    
    December 2021
39. DENG Y, Bai J, Cai J
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. Reply.
    N Engl J Med. 2021;385:2590-2591.
    PubMed    
    
    
    
40. MAGGIANI GSG, Bo M
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2590.
    PubMed    
    
    
    
41. STEFFEN HM, Bonner G, Middeke M
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2589-2590.
    PubMed    
    
    
    
42. CHU PJ
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2589.
    PubMed    
    
    
    
43. OSAWA S, Mori J
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2588-2589.
    PubMed    
    
    
    
44. HASSOUN PM
    Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;385:2361-2376.
    PubMed    
    
    
    November 2021
45. POLI F, Yusuf IH
    Retinopathy in Malignant Hypertension.
    N Engl J Med. 2021;385:1994.
    PubMed    
    
    
    
46. ELLISON DH, Welling P
    Insights into Salt Handling and Blood Pressure.
    N Engl J Med. 2021;385:1981-1993.
    PubMed    
    
    
    
47. AGARWAL R, Sinha AD, Cramer AE, Balmes-Fenwick M, et al
    Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2110730.
    PubMed     Abstract available
    
    
    September 2021
48. SANDBORN WJ, Feagan BG, D'Haens G, Wolf DC, et al
    Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2021;385:1280-1291.
    PubMed     Abstract available
    
    
    
49. FANG M, Selvin E
    Diabetes Treatment and Control in U.S. Adults. Reply.
    N Engl J Med. 2021;385:e30.
    PubMed    
    
    
    
50. SHOAG JE, Al Hussein Al Awamlh B, Rajagopalan S
    Diabetes Treatment and Control in U.S. Adults.
    N Engl J Med. 2021;385:e30.
    PubMed    
    
    
    
51. BRUNO S, Roosevelt TS
    Diabetes Treatment and Control in U.S. Adults.
    N Engl J Med. 2021;385:e30.
    PubMed    
    
    
    August 2021
52. ZHANG W, Zhang S, Deng Y, Wu S, et al
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021 Aug 30. doi: 10.1056/NEJMoa2111437.
    PubMed     Abstract available
    
    
    
53. NEAL B, Wu Y, Feng X, Zhang R, et al
    Effect of Salt Substitution on Cardiovascular Events and Death.
    N Engl J Med. 2021 Aug 29. doi: 10.1056/NEJMoa2105675.
    PubMed     Abstract available
    
    
    July 2021
54. BJORNSTAD P, Drews KL, Caprio S, Gubitosi-Klug R, et al
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:416-426.
    PubMed     Abstract available
    
    
    June 2021
55. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    PubMed    
    
    
    May 2021
56. LAU ES, Vaidya A, Schaefer IM, Scirica BM, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:e80.
    PubMed    
    
    
    
57. LEWIS CE, Fine LJ, Beddhu S, Cheung AK, et al
    Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
    N Engl J Med. 2021;384:1921-1930.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.